Benralizumab Helpful in Severe Eosinophilic Asthma

11:36 EDT 21 Sep 2016 | Medscape

Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, is safe and effective in treatment of severe uncontrolled, eosinophilic asthma, according to two new industry-funded studies.
Reuters Health Information

Original Article: Benralizumab Helpful in Severe Eosinophilic Asthma


More From BioPortfolio on "Benralizumab Helpful in Severe Eosinophilic Asthma"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...